Skip to main content
. 2017 Dec 22;96(51):e9411. doi: 10.1097/MD.0000000000009411

Figure 5.

Figure 5

MIP image of an 84-year-old female with DLBCL on chemotherapy. PET/CT was performed at an outside institution after completion of treatment. The initial report indicated diffuse bone marrow uptake suspicious for lymphomatous involvement (stage IV). Second-opinion review at our institution described the diffuse bone marrow uptake as reactive to endogenous and/or exogenous stimulation. Therefore, the PET/CT was reported as “no evidence of disease,” concordant with the bone marrow biopsy and the multidisciplinary staging as “complete remission.”